Angiotensin-converting enzyme inhibitors during the first trimester of pregnancy increase the incidence of fetal malformation, whereas calcium intake (1.0 to 2.0 g/day) prevents preeclampsia.
Atallah
Alvaro Nagib
AN
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D050071:Bone Density Conservation Agents / Q000008:administration & dosage*; D002136:Calcium, Dietary / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D016017:Odds Ratio; D011225:Pre-Eclampsia / Q000517:prevention & control*; D011247:Pregnancy; D011261:Pregnancy Trimester, First
D000806:Angiotensin-Converting Enzyme Inhibitors; D050071:Bone Density Conservation Agents; D002136:Calcium, Dietary